In our cohort, a comprehensive tumor profile including homologous recombination genes (i.e., ATM, PALB2, RAD50, RAD51, RAD51B, RAD51C, RAD51D, ...) was performed for 100 cases, finding pathogenic alterations in four tumor samples, as previously reported [59]. This evidence concerns the gene PALB2 and neoplasm.